The Human Reproduction Programme (HRP) originated in 1972 as a WHO special program to support and evaluate international research and development related to human reproduction, with particular reference to the needs of developing countries. The World Bank became a cosponsor-along with UNFPA, UNDP and WHO-of a re-structured "UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction" in FY88. The special program carries out two broad types of activities: (1) coordinating research through a global network; and (2) building national capacity in fertility and sexual and reproductive health research. A major HRP objective has been to monitor and provide information on the safety and efficacy of the most widely used contraceptives, which is an invaluable global public good. HRP has also engaged in basic and applied contraceptive research and in research on priority sexual and reproductive health problems that affect poor and vulnerable groups, particularly poor women and adolescents. The Bank brings to the program the benefits of its in-country project experience and understanding of programmatic needs, and a strong sense of priorities. This includes the corporate priority in the MDGs, specifically maternal and child health. This is a cosponsored program that benefits enormously from the Bank's expertise in donor coordination while the steady grant has facilitated leveraging of additional funds, especially the bilaterals and foundations.
Khama Odera Rogo
The World Bank
1818 H Street, NW, Washington, DC 20433